About
NFX is a venture firm focused on pre-seed & seed stage startups. Its goal is to transform how innovators are funded. NFX invests in early-stage companies located in the US and Israel. It focuses on seed-stage ventures, and sometimes also invests in pre-seed and Series A rounds. NFX invests in companies whose model is based on the "network effect", in which every user of the network profits from the additional of another investor.
NFX began in 2015 as a startup accelerator that invested $120,000 in each company that participated in the program. The first fund of $150 million, which was closed in November 2017, has invested in 25 companies, with an average investment of $2 million per seed company.
The second Fund, which was closed in May 2019, was one of the largest seed funds in Silicon Valley. The fund aimed at facilitating larger amounts than in the past in a large number of companies.
In February 2021, the firm has launched NFX.BIO, an early stage fund aimed at funding some of biotechs most successful Scientist-Founders.
In October 2021, the firm has launched a $450 Million Fund III dedicated solely to pre-seed and seed-stage startups.
Portfolio
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is NFX Capital's primary investment focus?
- NFX Capital primarily focuses on pre-seed and seed-stage startups, with an emphasis on companies whose models are based on the 'network effect'. They also invest in Series A rounds.
- How many funds has NFX Capital launched and what are their sizes?
- NFX Capital has launched four funds. The first fund, closed in November 2017, was $150 million. The second fund, closed in May 2019, was one of the largest seed funds in Silicon Valley. In October 2021, they launched a $450 million Fund III. In October 2025, NFX raised a fourth fund of $325 million.
- What is NFX Capital's average investment per seed company from its first fund?
- From its first $150 million fund, closed in November 2017, NFX Capital invested in 25 companies with an average investment of $2 million per seed company.
- Has NFX Capital shown a recent interest in specific sectors?
- Yes, NFX Capital launched NFX.BIO in February 2021, an early-stage fund for biotech scientist-founders. Additionally, in March 2022, Gigi Levy-Weiss's NFX announced plans to invest in climate-tech.
- Can you name some notable exits for NFX Capital's portfolio companies?
- Notable exits for NFX Capital include Hippo Insurance, which had a Public Offering in August 2021 with a $5 billion valuation, and C2i Genomics, acquired by Veracyte in January 2024 for $95 million.
- What is NFX Capital's most recent investment, according to startupim data?
- NFX Capital's most recent investment was in Q-Factor in April 2026, a $24 million seed funding round where NFX was a lead investor.
- Which sectors have seen the most investment activity from NFX Capital?
- According to startupim data, NFX Capital has shown the most investment activity in Business Software with 41 rounds, followed by Health Tech & Life Sciences with 25 rounds, and Media & Entertainment Technologies with 18 rounds.
- What is NFX Capital's approach to investment speed?
- NFX Capital launched an ultra-fast $20 million investment track in April 2024, aiming for a response within 9 days and funding within 3 weeks, specifically for Israeli AI and biotech startups.
- Who is a prominent founder of NFX Capital?
- Gigi Levy-Weiss is a prominent founder of NFX Capital.